Research Articles | Page 94 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Eltrombopag in aplastic anemia Jan 2015 Semin Hematol aplastic anemia
Overview of myelodysplastic syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates Jan 2019 Semin Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Anemia as the Main Manifestation of Myelodysplastic Syndromes Oct 2015 Semin Hematol myelodysplastic syndromes (MDS)
Impaired proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway Mar 2014 Stem Cells Dev myelodysplastic syndromes (MDS)
Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms Jul 2019 Surgical Pathology Clinic myelodysplastic syndromes (MDS)
Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency Oct 2019 The Journal of Clinical Investigation paroxysmal nocturnal hemoglobinuria (PNH)